1. Home
  2. VREX vs CADL Comparison

VREX vs CADL Comparison

Compare VREX & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Varex Imaging Corporation

VREX

Varex Imaging Corporation

HOLD

Current Price

$9.80

Market Cap

501.8M

Sector

Technology

ML Signal

HOLD

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$8.28

Market Cap

551.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VREX
CADL
Founded
2016
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
501.8M
551.7M
IPO Year
2016
2021

Fundamental Metrics

Financial Performance
Metric
VREX
CADL
Price
$9.80
$8.28
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
7
Target Price
$16.67
$19.00
AVG Volume (30 Days)
242.0K
1.9M
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
58.62
EPS
N/A
N/A
Revenue
$811,000,000.00
$125,000.00
Revenue This Year
$5.35
N/A
Revenue Next Year
$3.88
N/A
P/E Ratio
$238.60
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.76
$4.35
52 Week High
$14.57
$7.99

Technical Indicators

Market Signals
Indicator
VREX
CADL
Relative Strength Index (RSI) 32.50 76.18
Support Level $6.76 $4.80
Resistance Level $12.44 N/A
Average True Range (ATR) 0.69 0.53
MACD -0.15 0.15
Stochastic Oscillator 16.17 97.56

Price Performance

Historical Comparison
VREX
CADL

About VREX Varex Imaging Corporation

Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: